On a rainy Inauguration Day morning, dozens of students, archivists, librarians, professors and other concerned citizens gathered in a UCLA classroom, poring over the Department of Energy website. They sifted through pages covering a broad spectrum of topics, from energy-efficient buildings and solar power to transportation and bioenergy. The goal of Friday’s workshop, which ran more than six hours: To…
Molecular biologists at UC San Diego have unlocked the code that initiates transcription and regulates the activity of more than half of all human genes, an achievement that should provide scientists with a better understanding of how human genes are turned on and off. The discovery of this critical DNA sequence code—what molecular biologists term the “human Initiator”—is detailed in a…
The UCLA Sustainable LA Grand Challenge awarded its second round of competitive research grants this month, providing $1 million to eight new projects led by UCLA researchers who will study self-driving cars, improve ways to capture and distribute solar power, map wild mammals in urban L.A., and more. The Sustainable LA Grand Challenge is a university-wide research initiative to transition…
New UCLA-led research finds that Zika-linked abnormalities that occur in human fetuses are more extensive — and severe — than previously thought, with 46 percent of 125 pregnancies among Zika-infected women resulting in birth defects in newborns or ending in fetal death. The study, published in the New England Journal of Medicine, suggests that damage during fetal development from the…
Male pregnancy. A long, tube-shaped mouth with no teeth. A body covered with bony plates. These are the odd, quintessential features of seahorses, but why? Scientists dove into this question on Wednesday by publishing the first complete sequence of a seahorse genome. “We have discovered an array of changes in the genome, which helps to explain why the seahorse looks…
CRISPR/Cas9, a powerful genome editing tool, is showing promise for efficient correction of disease-causing mutations. For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a dual gene therapy approach to deliver key components of a CRISPR/Cas9-mediated gene targeting system to mice to treat hemophilia B. This disorder is also called factor…